HM

Hon-Wah Man

BS Bristol-Myers Squibb: 6 patents #17 of 598Top 3%
SP Signal Pharmaceuticals: 2 patents #1 of 54Top 2%
📍 Princeton, NJ: #13 of 368 inventorsTop 4%
🗺 New Jersey: #159 of 6,802 inventorsTop 3%
Overall (2019): #14,321 of 560,194Top 3%
8
Patents 2019

Issued Patents 2019

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10517873 Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use Marie Georges Beauchamps, Antonio Christian Ferretti, Robert Hilgraf, Mohit Atul Kothare, Mark A. Nagy +2 more 2019-12-31
10434095 3-(1-oxo-4-((4-((3-oxomorpholino)methyl)benzyl)oxy)isoindolin-2-yl)piperidine-2,6-dione and isotopologues thereof Alexander L. Ruchelman 2019-10-08
10385037 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same Alexander L. Ruchelman, George W. Muller, Roger Shen-Chu Chen 2019-08-20
10357489 Antiproliferative compounds and methods of use thereof Matthew D. Alexander, Gerald D. Artman, III, James Carmichael, Brian E. Cathers, Matthew D. Correa +12 more 2019-07-23
10252981 Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein Terrence Joseph Connolly, Periyandi Nagarajan, Chinnapillai Rajendiran, Jasti Venkateswarlu 2019-04-09
10226461 Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use Marie Georges Beauchamps, Mohit Atul Kothare, Nanfei Zou 2019-03-12
10189808 Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses Paul F. Fernandez, Antonio Christian Ferretti, Mohit Atul Kothare, Ying Li, Weihong Zhang 2019-01-29
10189814 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same Roger Shen-Chu Chen, George W. Muller, Alexander L. Ruchelman, Ehab M. Khalil, Weihong Zhang 2019-01-29